AU2001292499A1 - 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain - Google Patents

7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain

Info

Publication number
AU2001292499A1
AU2001292499A1 AU2001292499A AU9249901A AU2001292499A1 AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1 AU 2001292499 A AU2001292499 A AU 2001292499A AU 9249901 A AU9249901 A AU 9249901A AU 2001292499 A1 AU2001292499 A1 AU 2001292499A1
Authority
AU
Australia
Prior art keywords
pain
tetrahydropyridazino
pyridylethyl
dione
quinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001292499A
Other languages
English (en)
Inventor
Vernon Alford
Thomas Bare
Christine Barlaam
Dean Gordon Brown
Carey Lynn Horchler
Frances Marie Mclaren
Megan Murphy
Gary Banks Steelman
Rebecca Ann Urbanek
Edward Vacek
Wenhua Xiao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of AU2001292499A1 publication Critical patent/AU2001292499A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU2001292499A 2000-09-29 2001-09-28 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain Abandoned AU2001292499A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23663000P 2000-09-29 2000-09-29
US60236630 2000-09-29
PCT/SE2001/002125 WO2002026740A1 (en) 2000-09-29 2001-09-28 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione and the use thereof for the treatment of pain

Publications (1)

Publication Number Publication Date
AU2001292499A1 true AU2001292499A1 (en) 2002-04-08

Family

ID=22890309

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001292499A Abandoned AU2001292499A1 (en) 2000-09-29 2001-09-28 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain

Country Status (7)

Country Link
US (1) US6933297B2 (de)
EP (1) EP1325003B1 (de)
JP (1) JP2004509964A (de)
AT (1) ATE334982T1 (de)
AU (1) AU2001292499A1 (de)
DE (1) DE60121978D1 (de)
WO (1) WO2002026740A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001292500A1 (en) * 2000-09-29 2002-04-08 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain
WO2005122352A1 (de) * 2004-06-09 2005-12-22 Abb Technology Ag Gasisolierte schaltanlage mit ein sichtfenster zur optischen erfassung die schaltstellung der schaltkontakten
EP2167458B1 (de) 2007-05-29 2018-03-14 Intrexon Corporation Chirale diacylhydrazinliganden zum modulieren der expression exogener gene über einen ecdysonrezeptorkomplex
RU2711968C1 (ru) * 2018-11-22 2020-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Пермский национальный исследовательский политехнический университет" Анальгезирующее средство

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9507318D0 (en) 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds
US20030153571A1 (en) * 1999-12-23 2003-08-14 Brown Dean Gordon Method and composition for the treatment of pain
AU2420101A (en) 1999-12-23 2001-07-09 Astrazeneca Ab Method and composition for the treatment of pain
AU2001292500A1 (en) * 2000-09-29 2002-04-08 Astrazeneca Ab 1,2,5,10-tetrahydropyridazino(4,5-b)quinoline-1,10-diones and their use for the treatment of pain

Also Published As

Publication number Publication date
US6933297B2 (en) 2005-08-23
EP1325003B1 (de) 2006-08-02
WO2002026740A1 (en) 2002-04-04
JP2004509964A (ja) 2004-04-02
EP1325003A1 (de) 2003-07-09
US20040053930A1 (en) 2004-03-18
DE60121978D1 (de) 2006-09-14
ATE334982T1 (de) 2006-08-15

Similar Documents

Publication Publication Date Title
GEP20053602B (en) Aripiprazole for Oral Administration
HUP0100437A2 (hu) Szabályzott felszabadulású gyógyszerkészítmény tolterodin adagolására
TR200000129T2 (tr) Yepyeni spiroazabisiklik heterosiklik bileşikler.
AU7031500A (en) Therapeutic quinazoline compounds
BRPI0108977B8 (pt) compostos azacíclicos, composição farmacêutica e uso de um composto ou sal farmaceuticamente aceitável do mesmo
PT840601E (pt) Thip para o tratamento de desordens do sono
HUP0102728A2 (hu) Módszerek és transzdermális készítmények fájdalom csillapítására
BR0211305A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças ou condições e uso de um composto
WO1992019617A3 (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
GEP20022801B (en) Pyridazino [4,5-B]-Quinoline 5-Oxide Derivatives, Their Preparation and Their Use as Glycine Antagonists
MY137752A (en) Medicament for treating aseptic inflammations containing anemonin as effective component
GB9907571D0 (en) Compounds
AU2001246999A1 (en) New neurokinin antagonists for use as medicaments
HU9802897D0 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
AU2001292499A1 (en) 7-chloro-4-hydroxy-2-(2-pyridylethyl)-1,2,5,10- tetrahydropyridazino(4,5-b)quinoline-1,10-dione and the use thereof for the treatment of pain
TW200503666A (en) Treatment of type 1 diabetes with pde5 inhibitors
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
BG105434A (en) Sertraline oral concentrate
WO2001068076A8 (en) D-enantiomer of dfmo and methods of use thereof for treating cancer
MY133596A (en) Compound and method for the treatment of pain
BR9908838A (pt) Uso de um glicocorticóide, processeo para tratar glomerulonefrite aguda ou crÈnica, e, composição farmacêutica para tratar glomerulonefrite
GEP20053512B (en) S-Methyl-Dihydro-Ziprasidone for Treatment of Psychiatric and Ocular Disorders.
AU8900498A (en) Compounds and pharmaceutical compositions thereof for eliciting analgesic effects
WO2001007029A3 (en) Substituted guanidines and the use thereof
HUP9904578A2 (hu) Xanomelin alkalmazása bipoláris depresszió kezelésére szolgáló gyógyszerkészítmények előállítására